Skip to main content
Journal cover image

Regarding "The safety, efficacy and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions".

Publication ,  Journal Article
Manfredini, R; Boari, B; Gallerani, M; Portaluppi, F; Mehta, RH
Published in: J Vasc Surg
August 2003

Duke Scholars

Published In

J Vasc Surg

DOI

ISSN

0741-5214

Publication Date

August 2003

Volume

38

Issue

2

Start / End Page

411 / 412

Location

United States

Related Subject Headings

  • Vascular Diseases
  • Urokinase-Type Plasminogen Activator
  • Treatment Outcome
  • Tissue Plasminogen Activator
  • Thrombolytic Therapy
  • Plasminogen Activators
  • Humans
  • Catheterization, Peripheral
  • Cardiovascular System & Hematology
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Manfredini, R., Boari, B., Gallerani, M., Portaluppi, F., & Mehta, R. H. (2003). Regarding "The safety, efficacy and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions". J Vasc Surg, 38(2), 411–412. https://doi.org/10.1016/s0741-5214(03)00478-6
Manfredini, Roberto, Benedetta Boari, Massimo Gallerani, Francesco Portaluppi, and Rajendra H. Mehta. “Regarding "The safety, efficacy and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions".J Vasc Surg 38, no. 2 (August 2003): 411–12. https://doi.org/10.1016/s0741-5214(03)00478-6.
Manfredini, Roberto, et al. “Regarding "The safety, efficacy and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions".J Vasc Surg, vol. 38, no. 2, Aug. 2003, pp. 411–12. Pubmed, doi:10.1016/s0741-5214(03)00478-6.
Journal cover image

Published In

J Vasc Surg

DOI

ISSN

0741-5214

Publication Date

August 2003

Volume

38

Issue

2

Start / End Page

411 / 412

Location

United States

Related Subject Headings

  • Vascular Diseases
  • Urokinase-Type Plasminogen Activator
  • Treatment Outcome
  • Tissue Plasminogen Activator
  • Thrombolytic Therapy
  • Plasminogen Activators
  • Humans
  • Catheterization, Peripheral
  • Cardiovascular System & Hematology
  • 3202 Clinical sciences